SCHEMBL29022614

SCHEMBL29022614

O=C(OI)N1CCC2(CC1)Nc1ccccc1NC2=O

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 11/20 0.48
▸ DDB1 Q16531 4/20 0.43
▸ SCN5A Q14524 2/20 0.35
▸ SCN9A Q15858 2/20 0.35
▸ CYP3A4 P08684 3/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ OTUD7B Q6GQQ9 3/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30552358 0.83 CRBN (0.56) CRBNDDB1SCN5ASCN9AOTUD7B
SCHEMBL30552354 0.83 CRBN (0.56) CRBNDDB1SCN5ASCN9AOTUD7B
SCHEMBL25215318 0.78 CRBN (0.41) CRBNDDB1SCN5ASCN9ACYP3A4
SCHEMBL17350152 0.75 PDE7A (0.42) CRBNMAPK1KMT2AMEN1ALDH1A1
SCHEMBL19225163 0.72 PDE7A (0.47) CRBNMAPK1KMT2AMEN1ALDH1A1
SCHEMBL10758073 0.71 PDE7A (0.54) MAPK1KMT2AMEN1ALDH1A1
SCHEMBL30552386 0.70 BACE1 (0.47) CRBNMAPK1KMT2AMEN1ALDH1A1
SCHEMBL25386692 0.69 NR1H2 (0.48) MAPK1
SCHEMBL17524916 0.69 SCN9A (0.43) CRBNDDB1SCN9AMAPK1KMT2A
SCHEMBL6618655 0.68 CRBN (0.61) CRBNDDB1SCN5ASCN9AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN disclosed
Send feedback